<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="114178">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01616810</url>
  </required_header>
  <id_info>
    <org_study_id>REB 04-227C</org_study_id>
    <nct_id>NCT01616810</nct_id>
  </id_info>
  <brief_title>Lower Urinary Tract Symptoms Screening Questionnaire</brief_title>
  <acronym>LUTS-2</acronym>
  <official_title>Lower Urinary Tract Symptoms Screening Questionnaire Validation STudy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>St. Michael's Hospital, Toronto</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>St. Michael's Hospital, Toronto</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the validity of a screening tool which has been
      designed to detect the presence or absence of lower urinary tract symptoms in the general
      female population.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2007</start_date>
  <completion_date type="Actual">December 2011</completion_date>
  <primary_completion_date type="Actual">October 2007</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <primary_outcome>
    <measure>Presence or absence of lower urinary tract symptoms in the general female population</measure>
    <time_frame>Five years</time_frame>
    <description>To validate the effectiveness of a screening tool in detecting the presence or absence of lower urinary tract symptoms in the general female population.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">300</enrollment>
  <condition>Cystocele</condition>
  <arm_group>
    <arm_group_label>observation</arm_group_label>
    <description>Healthy participants</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Healthy participants, 18 years of age and older with any gynecological symptoms other than
        lower urinary tract symptoms or pelvic floor dysfunction
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy participants, 18 years of age and older with any gynecological symptoms

        Exclusion Criteria:

          -  Patients with lower urinary tract symptoms and pelvic floor dysfunction
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dana Soroka, MD, FRCS(C)</last_name>
    <role>Principal Investigator</role>
    <affiliation>St. Michael's Hospital, Toronto</affiliation>
  </overall_official>
  <verification_date>June 2012</verification_date>
  <lastchanged_date>June 8, 2012</lastchanged_date>
  <firstreceived_date>August 26, 2011</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>urinary tract</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Lower Urinary Tract Symptoms</mesh_term>
    <mesh_term>Cystocele</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
